Skip to Content Skip to Search

Analyst consensus

The consensus estimates are collected by the company and based on the estimates of brokerage firms covering GlaxoSmithKline. Please ensure you have read and acknowledged the disclaimer prior to reviewing the information provided.

FY2020-24 figures are as at 31/12/2020

Please select...
£m (unless stated) 2020 2021 2022 2023 2024 2020-2024 n=
Turnover 34,129 35,309 36,837 38,204 40,060 16
Cost of sales (10,081) (10,354) (10,750) (11,084) (11,589) 16
Selling, general and administration (10,744) (10,897) (11,124) (11,408) (11,801) 16
Research and Development (4,620) (5,092) (5,335) (5,482) (5,724) 16
Royalty income 303 319 341 367 222 16
Operating profit 8,987 9,285 9,968 10,596 11,169 16
Net finance costs (838) (833) (813) (777) (750) 16
Associates 46 34 33 33 33 16
Profit before tax 8,195 8,486 9,188 9,853 10,452 16
Taxation (1,321) (1,500) (1,705) (1,851) (1,965) 16
Tax Rate 16.1% 17.7% 18.6% 18.8% 18.8% 16
Profit after tax  6,874 6,987 7,483 8,002 8,487 16
Minority interests (1,102) (1,177) (1,253) (1,314) (1,361) 16
Profit attributable to shareholders 5,772 5,810 6,230 6,688 7,126 16
WANS (m) 4,974 4,990 5,009 5,027 5,043 16
Earnings per share (p) 116.0 116.4 124.4 133.1 141.3 16
Dividend per share (p) 80.0 80.0 80.0 80.3 80.9 14
Free Cash Flow 4,803 4,993 5,564 6,304 6,635 10
Net Debt (22,630) (21,955) (20,216) (18,069) (15,622) 14
             
USD / GBP 1.28 1.32 1.32 1.32 1.32 16
EUR / GBP 1.13 1.11 1.12 1.12 1.12 15
JPY / GBP 137 138 138 138 138 11

The firms included are: Bank of America, Barclays, Berenberg, Citi, Cowen, Credit Suisse, Exane, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Morgan Stanley, Redburn, SVB Leerink, UBS, Wolfe Research

Turnover £m 2020 2021 2022 2023 2024 2020-2024 n=
Anoro 545 573 600 622 640 16
Arnuity 47 51 53 55 56 16
Incruse 245 252 261 269 278 16
Relvar/Breo 1,113 1,096 1,111 1,119 1,127 16
Trelegy 813 1,059 1,271 1,453 1,601 16
Ellipta portfolio 2,763 3,031 3,296 3,518 3,701 16
Nucala 968 1,104 1,212 1,288 1,347 16
Total Respiratory 3,731 4,136 4,508 4,805 5,048 16
             
Tivicay 1,555 1,474 1,416 1,360 1,302 14
Triumeq 2,310 2,104 1,967 1,856 1,757 14
Juluca 490 589 659 704 735 15
Dovato 349 635 923 1,152 1,336 15
Dolutegravir based regimens 4,700 4,811 4,972 5,068 5,112 16
Cabotegravir +/- rilpivirine 0 81 219 378 548 16
Rukobia (fostemsavir) 17 90 151 205 250 16
Epzicom/Kivexa 34 25 20 17 14 15
HIV 4,885 5,112 5,447 5,742 5,994 16
             
Benylsta 708 805 898 971 1,032 16
             
Zejula 364 531 713 867 994 16
             
Advair (US) 453 316 256 219 195 16
Seretide (ex US) 1,094 969 865 779 709 16
Seretide/Advair 1,547 1,285 1,121 997 904 16
Flixotide/Flovent 454 408 383 360 341 16
Ventolin 735 641 599 570 546 16
Avamys/Veramyst 297 290 286 256 234 14
Established Respiratory 3,261 2,831 2,581 2,367 2,198 15
Other Established Pharmaceuticals 4,140 3,905 3,704 3,487 3,316 15
Established Pharmaceuticals 7,401 6,736 6,285 5,854 5,514 16
             
Blenrep (belantamab mafodotin) 32 150 299 481 643 16
dostarlimab 3 56 121 196 260 13
daprodustat 2 15 59 127 198 14
             
Pharmaceuticals 17,129 17,582 18,439 19,192 19,950 16

The firms included are: Bank of America, Barclays, Berenberg, Citi, Cowen, Credit Suisse, Exane, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Morgan Stanley, Redburn, SVB Leerink, UBS, Wolfe Research

Turnover £m 2020 2021 2022 2023 2024 2020-2024 n=
Bexsero 625 707 749 775 795 15
Menveo 247 269 279 287 292 15
Other Meningitis 87 81 82 82 82 4
Meningitis 960 1,057 1,110 1,144 1,170 16
Fluarix/Flulaval 625 655 688 716 741 16
Shingrix 1,953 2,412 2,602 2,786 3,393 16
Boostrix 487 525 540 549 556 15
Cervarix 113 104 103 103 103 14
Hepatitis 585 664 731 755 774 15
Infanrix, Pediarix 624 652 668 675 681 15
Rotarix 560 576 589 600 613 15
Synflorix 432 450 453 450 444 15
Vaccines 6,796 7,604 8,006 8,320 9,109 16

The firms included are: Bank of America, Barclays, Berenberg, Citi, Cowen, Credit Suisse, Exane, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Morgan Stanley, Redburn, SVB Leerink, UBS, Wolfe Research

Turnover £m 2020 2021 2022 2023 2024 2020-2024 n=
Oral Care 2,763 2,864 2,965 3,070 3,173 12
Pain Relief 2,193 2,247 2,322 2,400 2,478 12
Respiratory health 1,299 1,331 1,375 1,416 1,459 12
VMS 1,510 1,559 1,612 1,663 1,711 12
Digestive Health and other 1,903 1,996 2,053 2,100 2,141 12
Brands divested and under review 519 120 56 37 32 12
Consumer Health 10,186 10,117 10,384 10,686 10,994 16

The firms included are: Bank of America, Barclays, Berenberg, Citi, Cowen, Credit Suisse, Exane, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Morgan Stanley, Redburn, SVB Leerink, UBS, Wolfe Research

Back to top